Published in Br J Haematol on October 01, 2003
Cooperative Study of The Clinical Course of Sickle Cell Disease | NCT00005277
Evaluation of the Hemostatic Potential in Sickle Cell Disease Patients | NCT02565082
Albuminuria Reduction With Renin Angiotensin System Inhibitors in SCA Patients (RAND) | NCT01195818
Diastolic dysfunction is an independent risk factor for death in patients with sickle cell disease. J Am Coll Cardiol (2007) 2.76
Hemodynamic and functional assessment of patients with sickle cell disease and pulmonary hypertension. Am J Respir Crit Care Med (2007) 2.68
Definitions of the phenotypic manifestations of sickle cell disease. Am J Hematol (2010) 2.55
Venous thromboembolism in adults with sickle cell disease: a serious and under-recognized complication. Am J Med (2013) 2.37
Platelet activation in patients with sickle disease, hemolysis-associated pulmonary hypertension, and nitric oxide scavenging by cell-free hemoglobin. Blood (2007) 2.31
Left ventricular hypertrophy and diastolic dysfunction in children with sickle cell disease are related to asleep and waking oxygen desaturation. Blood (2010) 2.19
A randomised comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell disease. Br J Haematol (2007) 1.77
Abnormal autonomic cardiac response to transient hypoxia in sickle cell anemia. Physiol Meas (2008) 1.60
Cardiomyopathy With Restrictive Physiology in Sickle Cell Disease. JACC Cardiovasc Imaging (2016) 1.42
Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management. ScientificWorldJournal (2012) 1.40
The critical roles of platelet activation and reduced NO bioavailability in fatal pulmonary arterial hypertension in a murine hemolysis model. Blood (2010) 1.35
Cardiovascular abnormalities in sickle cell disease. J Am Coll Cardiol (2012) 1.31
Identification of genetic polymorphisms associated with risk for pulmonary hypertension in sickle cell disease. Blood (2008) 1.28
Cardiopulmonary complications leading to premature deaths in adult patients with sickle cell disease. Am J Hematol (2010) 1.28
Pulmonary hypertension in sickle cell disease: relevance to children. Pediatr Hematol Oncol (2007) 1.21
Hemoglobin sickle cell disease complications: a clinical study of 179 cases. Haematologica (2012) 1.20
Hemodynamic predictors of mortality in adults with sickle cell disease. Am J Respir Crit Care Med (2013) 1.16
Lipid levels in sickle-cell disease associated with haemolytic severity, vascular dysfunction and pulmonary hypertension. Br J Haematol (2010) 1.13
Pulmonary embolism in sickle cell disease: a case-control study. J Thromb Haemost (2012) 1.12
Hydroxyurea and acute painful crises in sickle cell anemia: effects on hospital length of stay and opioid utilization during hospitalization, outpatient acute care contacts, and at home. J Pain Symptom Manage (2010) 1.09
Nitric oxide and arginine dysregulation: a novel pathway to pulmonary hypertension in hemolytic disorders. Curr Mol Med (2008) 1.07
Asthma morbidity and treatment in children with sickle cell disease. Expert Rev Respir Med (2011) 1.00
Immunomodulatory drug CC-4047 is a cell-type and stimulus-selective transcriptional inhibitor of cyclooxygenase 2. J Clin Immunol (2007) 0.97
Haematology and neurology. J Neurol Neurosurg Psychiatry (2007) 0.96
Sickle cell disease and venous thromboembolism: what the anticoagulation expert needs to know. J Thromb Thrombolysis (2013) 0.93
Mechanistic insights and characterization of sickle cell disease-associated cardiomyopathy. Circ Cardiovasc Imaging (2014) 0.92
Infections in thalassemia and hemoglobinopathies: focus on therapy-related complications. Mediterr J Hematol Infect Dis (2009) 0.88
Paradoxical protection from atherosclerosis and thrombosis in a mouse model of sickle cell disease. Br J Haematol (2013) 0.87
Cause of death among Ghanaian adolescents in Accra using autopsy data. BMC Res Notes (2011) 0.87
Role of the hemostatic system on sickle cell disease pathophysiology and potential therapeutics. Hematol Oncol Clin North Am (2014) 0.84
Autopsy findings and pattern of mortality in Nigerian sickle cell disease patients. Pan Afr Med J (2014) 0.84
Coagulation abnormalities of sickle cell disease: Relationship with clinical outcomes and the effect of disease modifying therapies. Blood Rev (2015) 0.80
Elevated hypercoagulability markers in hemoglobin SC disease. Haematologica (2015) 0.80
Pathophysiology and treatment of pulmonary hypertension in sickle cell disease. Blood (2016) 0.80
Myocardial infarction in sickle cell disease: use of translational imaging to diagnose an under-recognized problem. J Cardiovasc Transl Res (2012) 0.79
Knowledge insufficient: the management of haemoglobin SC disease. Br J Haematol (2016) 0.78
Heart rate recovery is impaired after maximal exercise testing in children with sickle cell anemia. J Pediatr (2014) 0.77
Tricuspid regurgitant velocity elevation in a three-year old child with sickle cell anemia and recurrent acute chest syndromes reversed not by hydroxyurea but by bone marrow transplantation. Hematol Rep (2011) 0.77
Echocardiographic evaluation of left ventricular diastolic and systolic function in Saudi patients with sickle cell disease. J Saudi Heart Assoc (2012) 0.77
Secondhand Smoke Is an Important Modifiable Risk Factor in Sickle Cell Disease: A Review of the Current Literature and Areas for Future Research. Int J Environ Res Public Health (2016) 0.75
Sudden Death in Sickle Cell Anaemia: Report of Three Cases with Brief Review of Literature. Indian J Hematol Blood Transfus (2015) 0.75
Associations of Prolonged QTc in Sickle Cell Disease. PLoS One (2016) 0.75
Hematological disorders and pulmonary hypertension. World J Cardiol (2016) 0.75
Successful outcome of three patients with sickle-cell disease and fat embolism syndrome treated with intensive exchange transfusion. Clin Case Rep (2016) 0.75
Immunogenicity of pneumococcal vaccination in a patient with sickle hemoglobinopathy: a case report. Clin Case Rep (2015) 0.75
Pulmonary hypertension among 5 to 18 year old children with sickle cell anaemia in Nigeria. PLoS One (2017) 0.75
Association between diffuse myocardial fibrosis and diastolic dysfunction in sickle cell anemia. Blood (2017) 0.75
Cav3.1 (alpha1G) T-type Ca2+ channels mediate vaso-occlusion of sickled erythrocytes in lung microcirculation. Circ Res (2003) 1.66
Comparative effects of simvastatin and atorvastatin in hypercholesterolemic patients with characteristics of metabolic syndrome. Clin Ther (2003) 1.55
Lipid-altering efficacy of ezetimibe plus statin and statin monotherapy and identification of factors associated with treatment response: a pooled analysis of over 21,000 subjects from 27 clinical trials. Atherosclerosis (2012) 1.19
A primary care provider's guide to preventive and acute care management of adults and children with sickle cell disease. J Am Acad Nurse Pract (2009) 1.16
Long-term treatment with finasteride 1 mg decreases the likelihood of developing further visible hair loss in men with androgenetic alopecia (male pattern hair loss). Eur J Dermatol (2008) 1.15
Physicians' attitude and practices in sickle cell disease pain management. J Palliat Care (2005) 1.09
Progression of hair loss in men with androgenetic alopecia (male pattern hair loss): long-term (5-year) controlled observational data in placebo-treated patients. Eur J Dermatol (2008) 1.07
Effects of ezetimibe added to statin therapy on markers of cholesterol absorption and synthesis and LDL-C lowering in hyperlipidemic patients. Atherosclerosis (2012) 0.85
Perivascular fibrosis in the bone marrow in sickle cell disease. Arch Pathol Lab Med (2004) 0.85
Hospital presentation after stroke in a community sample: the Mobile Stroke Project. South Med J (2002) 0.84
Misclassification of pulmonary hypertension in adults with sickle hemoglobinopathies using Doppler echocardiography. South Med J (2012) 0.83
A double-blind, placebo-controlled phase II study of the efficacy and safety of 2,2-dimethylbutyrate (HQK-1001), an oral fetal globin inducer, in sickle cell disease. Am J Hematol (2014) 0.83
Effects of simvastatin on C-reactive protein in mixed hyperlipidemic and hypertriglyceridemic patients. Am J Cardiol (2002) 0.82
Elevated high sensitivity C-reactive protein levels in aging men with low testosterone. Aging Male (2010) 0.82
The comparative efficacy of ezetimibe added to atorvastatin 10 mg versus uptitration to atorvastatin 40 mg in subgroups of patients aged 65 to 74 years or greater than or equal to 75 years. J Geriatr Cardiol (2011) 0.82
Bayesian inference for multivariate meta-analysis Box-Cox transformation models for individual patient data with applications to evaluation of cholesterol-lowering drugs. Stat Med (2013) 0.81
Cardiofaciocutaneous syndrome (CFC) with congenital peripheral neuropathy and nonorganic malnutrition: an autopsy study. Am J Med Genet A (2005) 0.79
Meta-analysis methods and models with applications in evaluation of cholesterol-lowering drugs. Stat Med (2012) 0.79
Sickle acute lung injury: role of prevention and early aggressive intervention strategies on outcome. Clin Chest Med (2006) 0.78
Recurrent hepatoblastoma with localization by PET-CT. Pediatr Radiol (2005) 0.77
Increased occurrence of marked elevations of lipoprotein(a) in ageing, hypercholesterolaemic men with low testosterone. Aging Male (2010) 0.76
Smooth muscle gamma-actin promoter regulation by RhoA and serum response factor signaling. Biochim Biophys Acta (2003) 0.76
Instinctive Clinical Teaching: Erasing the Mental Boundary Between Clinical Education and Patient Care to Promote Natural Learning. J Grad Med Educ (2014) 0.75